A*Star and Cytos advance Singapore's first flu vaccine
Sanofi to submit JAK inhibitor for MF
Bayer buys herbal drugmaker Steigerwald
Indian essential drug prices to fall "up to 80%"
UCB and IBM bet on big data to help epilepsy
Roche files next-generation Rituxan in USA, EU
AZ puts three targeted cancer drugs into Phase III
Europe must pay its way for innovation: Novo chief
Sanofi/Regeneron begin two more trials for RA drug
Signs emerged in March that the retinal imaging specialist Optos might be approaching a pothole in the road. The 90% drop in profits announced by the company this morning, however, was...